seems that
you are more interested in arguing.
yes, I talked to the company, no, not the FDA, but I read what I needed on the FDA suite
ever done a metrics sheet? I don't know what the market share or the pricing will be, that's why you do a broad projection. I am trying to get real data, and have some
fyi, 15% at $40 puts stock at $1.8 with no multiple.
38M Plavix users US
i've read all of your posts, and found some helpful, but mostly emotion and doubt.
VRML, ANZ, all had naysayers...